Michelle Tallquist received a BA in Chemistry from Kalamazoo College in 1989. After receiving her degree, she worked several years as an analytical chemist at The Upjohn Company. In 1992 she entered graduate school at the Mayo Clinic, where she studied immunology. For her thesis work she investigated the molecular basis of graft rejection. Her post-doctoral work was carried out in Seattle at the Fred Hutchinson Cancer Research Center where she used the power of mouse molecular genetics to unravel Platelet Derived Growth Factor signaling in vivo. Currently, she is an assistant professor at University of Texas Southwestern Medical Center at Dallas. She continues to study receptor tyrosine kinase signaling and has received several junior investigator awards including: the Scientist Development Award from the American Heart Association and the Basil O’Connor Starter Scholar Research Award from the March of Dimes.
